Results 21 to 30 of about 27,614 (216)

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development [PDF]

open access: yesReviews in Clinical Medicine, 2020
Aspergillosis is a common fungal infection with systemic characteristics, which is caused by various species of Aspergillus. The infection could develop in immunocompromised and immunocompetent patients under specific circumstances. Based on the clinical
Ali AL-Janabi
doaj   +1 more source

Semiinvasive Aspergillosis: A Diagnosis to Consider in a Seemingly Immunocompetent Patient with a Pulmonary Nodule, Haemoptysis and Structural Lung Disease

open access: yesActa Medica, 2009
Semiinvasive pulmonary aspergillosis is an indolent form of pulmonary aspergillosis, which is seen mainly in patients who are mildly immunocompromised with underlying chronic lung diseases.
Francisco José Fernández-Fernández   +2 more
doaj   +1 more source

Pulmonary aspergillosis

open access: yesDiagnostic and Interventional Imaging, 2015
Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L.   +5 more
openaire   +2 more sources

Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease

open access: yesFrontiers in Immunology, 2022
Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates.
Liuyang Cai   +14 more
doaj   +1 more source

Pathogenicity and virulence of Aspergillus fumigatus

open access: yesVirulence, 2023
Pulmonary infections caused by the mould pathogen Aspergillus fumigatus are a major cause of morbidity and mortality globally. Compromised lung defences arising from immunosuppression, chronic respiratory conditions or more recently, concomitant viral or
Kayleigh Earle   +7 more
doaj   +1 more source

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis

open access: yesMedical Mycology Case Reports, 2018
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino   +4 more
doaj   +1 more source

Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study

open access: yesDiagnostics, 2023
Invasive pulmonary aspergillosis is associated with high mortality. For diagnosis, galactomannan-antigen in serum and bronchoalveolar lavage fluid is recommended, with higher sensitivity in bronchoalveolar lavage fluid.
Kathrin Rothe   +6 more
doaj   +1 more source

COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study

open access: yesJournal of Fungi, 2023
Background: The incidence and outcome of pulmonary aspergillosis in coronavirus disease (COVID-19) patients on extracorporeal membrane oxygenation (ECMO) are unknown and have not been fully addressed.
Ali Nuh   +7 more
doaj   +1 more source

Pulmonary aspergillosis associated with antineutrophil cytoplasmic antibody-positive vasculitis involving skin and peripheral nerves

open access: yesJournal of the Indian Academy of Geriatrics
Invasive pulmonary aspergillosis is the most common cause of invasive fungal infection. Vasculitis secondary to bacterial, fungal, viral, and parasitic infections is documented in the literature.
Abhijith Rajaram Rao   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy